Diagnosis and Treatment of Hyperfibrinolysis in Trauma (A European Perspective)

Seminars in Thrombosis and Hemostasis

Volumn 43, Issue 2, 2017, Pages 224-234

  Gall, Lewis S ^a   Brohi, Karim ^a   Davenport, Ross A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

coagulopathy; fibrinolysis; hemorrhage; tranexamic acid; trauma

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ARTICLE; BLOOD CLOTTING DISORDER; FIBRINOLYSIS; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; HYPERFIBRINOLYSIS; INJURY; INJURY SEVERITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOSIS; TREATMENT INDICATION; BLOOD; PHYSIOLOGY; WOUNDS AND INJURIES;

FIBRINOLYSIS; HUMANS; WOUNDS AND INJURIES;

EID: 85013487446     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0036-1598001     Document Type: Article

References (126)

1. Raza I Davenport R Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients J Thromb Haemost 2013 11 2 307 314
2. Chapin J C Hajjar K A Fibrinolysis and the control of blood coagulation Blood Rev 2015 29 1 17 24
3. Brohi K Cohen M J Ganter M T, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis J Trauma 2008 64 5 1211 1217, discussion 1217
4. Davenport R A Guerreiro M Frith D, et al. Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy Anesthesiology 2017 126 1 115 127
5. Kutcher M E Redick B J McCreery R C, et al. Characterization of platelet dysfunction after trauma J Trauma Acute Care Surg 2012 73 1 13 19
6. Hunt B J Segal H Hyperfibrinolysis J Clin Pathol 1996 49 12 958
7. Kauvar D S Lefering R Wade C E Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations J Trauma 2006 60 (6, Suppl): S3 S11
8. Moore E E Moore H B Gonzalez E Sauaia A Banerjee A Silliman C C Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient Transfusion 2016 56 02 S110 S114
9. Dunbar N M Chandler W L Thrombin generation in trauma patients Transfusion 2009 49 12 2652 2660
10. Levin E G Loskutoff D J Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators J Cell Biol 1982 94 3 631 636
11. Levin E G Santell L Osborn K G The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location J Cell Sci 1997 110 (Pt 2): 139 148
12. Levin E G del Zoppo G J Localization of tissue plasminogen activator in the endothelium of a limited number of vessels Am J Pathol 1994 144 5 855 861
13. Huber D Cramer E M Kaufmann J E, et al. Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo Blood 2002 99 10 3637 3645
14. Emeis J J van den Eijnden-Schrauwen Y van den Hoogen C M de Priester W Westmuckett A Lupu F An endothelial storage granule for tissue-type plasminogen activator J Cell Biol 1997 139 1 245 256
15. Yau J W Teoh H Verma S Endothelial cell control of thrombosis BMC Cardiovasc Disord 2015 15 130
16. Van De Craen B Declerck P J Gils A The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo Thromb Res 2012 130 4 576 585
17. Fay W P Eitzman D T Shapiro A D Madison E L Ginsburg D Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and-independent mechanisms Blood 1994 83 2 351 356
18. Declerck P J Alessi M C Verstreken M Kruithof E K Juhan-Vague I Collen D Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Blood 1988 71 1 220 225
19. Booth N A Simpson A J Croll A Bennett B MacGregor I R Plasminogen activator inhibitor (PAI-1) in plasma and platelets Br J Haematol 1988 70 3 327 333
20. Schleef R R Sinha M Loskutoff D J Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator J Lab Clin Med 1985 106 4 408 415
21. Brogren H Karlsson L Andersson M Wang L Erlinge D Jern S Platelets synthesize large amounts of active plasminogen activator inhibitor 1 Blood 2004 104 13 3943 3948
22. Brogren H Wallmark K Deinum J Karlsson L Jern S Platelets retain high levels of active plasminogen activator inhibitor 1 PLoS One 2011 6 11 e26762
23. Moore H B Moore E E Gonzalez E, et al. Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury Shock 2015 43 1 39 46
24. Levi M Biemond B J van Zonneveld A J ten Cate J W Pannekoek H Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis Circulation 1992 85 1 305 312
25. Mosnier L O Buijtenhuijs P Marx P F Meijers J CM Bouma B N Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets Blood 2003 101 12 4844 4846
26. Mitchell J L Lionikiene A S Fraser S R Whyte C S Booth N A Mutch N J Functional factor XIII-A is exposed on the stimulated platelet surface Blood 2014 124 26 3982 3990
27. Holcomb J B Tilley B C Baraniuk S, et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial JAMA 2015 313 5 471 482
28. Holcomb J B Wade C E Michalek J E, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients Ann Surg 2008 248 3 447 458
29. Zink K A Sambasivan C N Holcomb J B Chisholm G Schreiber M A A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study Am J Surg 2009 197 5 565 570, discussion 570
30. Whyte C S Mitchell J L Mutch N J Platelet-mediated modulation of fibrinolysis Semin Thromb Hemost 2017 43 2 115 128
31. Rourke C Curry N Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes J Thromb Haemost 2012 10 7 1342 1351
32. Brohi K Singh J Heron M Coats T Acute traumatic coagulopathy J Trauma 2003 54 6 1127 1130
33. Floccard B Rugeri L Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study Injury 2012 43 1 26 32
34. Davenport R Khan S Management of major trauma haemorrhage: treatment priorities and controversies Br J Haematol 2011 155 5 537 548
35. Davenport R A Brohi K Cause of trauma-induced coagulopathy Curr Opin Anaesthesiol 2016 29 2 212 219
36. Boldt J Papsdorf M Rothe A Kumle B Piper S Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med 2000 28 2 445 450
37. Schreiber M A Differding J Thorborg P Mayberry J C Mullins R J Hypercoagulability is most prevalent early after injury and in female patients J Trauma 2005 58 3 475 480, discussion 480-481
38. Chakrabarti R Hocking E D Fearnley G R Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen J Clin Pathol 1969 22 6 659 662
39. Gando S Disseminated intravascular coagulation in trauma patients Semin Thromb Hemost 2001 27 6 585 592
40. Innes D Sevitt S Coagulation and fibrinolysis in injured patients J Clin Pathol 1964 17 1 13
41. Brohi K Cohen M J Ganter M T Matthay M A Mackersie R C Pittet J-F Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007 245 5 812 818
42. Cohen M J Call M Nelson M, et al. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients Ann Surg 2012 255 2 379 385
43. Cohen M J Kutcher M Redick B, et al; PROMMTT Study Group. Clinical and mechanistic drivers of acute traumatic coagulopathy J Trauma Acute Care Surg 2013 75 1 01 S40 S47
44. Chesebro B B Rahn P Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice Shock 2009 32 6 659 665
45. Brohi K Cohen M J Davenport R A Acute coagulopathy of trauma: mechanism, identification and effect Curr Opin Crit Care 2007 13 6 680 685
46. Cohen M J Brohi K Ganter M T Manley G T Mackersie R C Pittet J-F Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway J Trauma 2007 63 6 1254 1261, discussion 1261-1262
47. Gando S Sawamura A Hayakawa M Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature Ann Surg 2011 254 1 10 19
48. Gando S Wada H Thachil J; Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH). Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS) J Thromb Haemost 2013 11 5 826 835
49. Kooistra T Schrauwen Y Arts J Emeis J J Regulation of endothelial cell t-PA synthesis and release Int J Hematol 1994 59 4 233 255
50. Bärtsch P Haeberli A Hauser K Gubser A Straub P W Fibrinogenolysis in the absence of fibrin formation in severe hypobaric hypoxia Aviat Space Environ Med 1988 59 5 428 432
51. Hayakawa M Sawamura A Gando S, et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase Surgery 2011 149 2 221 230
52. Gando S Acute coagulopathy of trauma shock and coagulopathy of trauma: a rebuttal. You are now going down the wrong path J Trauma 2009 67 2 381 383
53. Viersen V A Greuters S Korfage A R, et al. Hyperfibrinolysis in out of hospital cardiac arrest is associated with markers of hypoperfusion Resuscitation 2012 83 12 1451 1455
54. Schöchl H Cadamuro J Seidl S, et al. Hyperfibrinolysis is common in out-of-hospital cardiac arrest: results from a prospective observational thromboelastometry study Resuscitation 2013 84 4 454 459
55. Johansson P I Stensballe J Rasmussen L S Ostrowski S R High circulating adrenaline levels at admission predict increased mortality after trauma J Trauma Acute Care Surg 2012 72 2 428 436
56. von Känel R Dimsdale J E Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo Eur J Haematol 2000 65 6 357 369
57. Kowalski E Kopec M Niewiarowski S An evaluation of the euglobulin method for the determination of fibrinolysis J Clin Pathol 1959 12 3 215 218
58. Boudjeltia K Z Cauchie P Remacle C, et al. A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time BMC Biotechnol 2002 2 8
59. Katz J Lurie A Becker D Metz J The euglobulin lysis time test: an ineffectual monitor of the therapeutic inhibition of fibrinolysis J Clin Pathol 1970 23 6 529 532
60. Kutcher M E Cripps M W McCreery R C, et al. Criteria for empiric treatment of hyperfibrinolysis after trauma J Trauma Acute Care Surg 2012 73 1 87 93
61. Chapman M P Moore E E Moore H B, et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients J Trauma Acute Care Surg 2016 80 1 16 23, discussion 23-25
62. Ostrowski S R Sørensen A M Larsen C F Johansson P I Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study Scand J Trauma Resusc Emerg Med 2011 19 64
63. Cardenas J C Matijevic N Baer L A Holcomb J B Cotton B A Wade C E Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients Shock 2014 41 6 514 521
64. Lisman T Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis Semin Thromb Hemost 2016 10.1055/s-0036-1585081
65. Hagemo J S Christiaans S C Stanworth S J, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study Crit Care 2015 19 97
66. Carroll R C Craft R M Langdon R J, et al. Early evaluation of acute traumatic coagulopathy by thrombelastography Transl Res 2009 154 1 34 39
67. Jeger V Zimmermann H Exadaktylos A K Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries? J Trauma 2009 66 4 1253 1257
68. Davenport R Manson J De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy Crit Care Med 2011 39 12 2652 2658
69. Inaba K Rizoli S Veigas P V, et al; Viscoelastic Testing in Trauma Consensus Panel. 2014 Consensus conference on viscoelastic test-based transfusion guidelines for early trauma resuscitation: report of the panel J Trauma Acute Care Surg 2015 78 6 1220 1229
70. National Institute for Health and Care Excellence (NICE) Major trauma: assessment and initial management Guideline 39. 2016. Available at: www.nice.org.uk/guidance/ng39. Accessed September 11, 2016
71. Hunt H Stanworth S Curry N, et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding Cochrane Database Syst Rev 2015 2 2 CD010438
72. Gonzalez E Moore E E Moore H B, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays Ann Surg 2016 263 6 1051 1059
73. TACTIC partners iTACTIC Trial: Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy Available at: www.tacticgroup.dk/. Accessed September 11, 2016
74. Rossaint R Bouillon B Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition Crit Care 2016 20 100
75. Levrat A Gros A Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients Br J Anaesth 2008 100 6 792 797
76. Schöchl H Frietsch T Pavelka M Jámbor C Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry J Trauma 2009 67 1 125 131
77. Theusinger O M Wanner G A Emmert M Y, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma Anesth Analg 2011 113 5 1003 1012
78. Tauber H Innerhofer P Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’ Br J Anaesth 2011 107 3 378 387
79. Cotton B A Harvin J A Kostousouv V, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration J Trauma Acute Care Surg 2012 73 2 365 370, discussion 370
80. Ives C Inaba K Branco B C, et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma J Am Coll Surg 2012 215 4 496 502
81. Kashuk J L Moore E E Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma Ann Surg 2010 252 3 434 442, discussion 443-444
82. Dekker S E Viersen V A Duvekot A, et al. Lysis onset time as diagnostic rotational thromboelastometry parameter for fast detection of hyperfibrinolysis Anesthesiology 2014 121 1 89 97
83. Chapman M P Moore E E Ramos C R, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy J Trauma Acute Care Surg 2013 75 6 961 967, discussion 967
84. Moore H B Moore E E Liras I N, et al. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients J Am Coll Surg 2016 222 4 347 355
85. Moore H B Moore E E Gonzalez E, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy J Trauma Acute Care Surg 2014 77 6 811 817, discussion 817
86. Pommerening M J Goodman M D Farley D L, et al. Early diagnosis of clinically significant hyperfibrinolysis using thrombelastography velocity curves J Am Coll Surg 2014 219 6 1157 1166
87. Leebeek F WG Rijken D C The fibrinolytic status in liver diseases Semin Thromb Hemost 2015 41 5 474 480
88. Harr J N Moore E E Chin T L, et al. Viscoelastic hemostatic fibrinogen assays detect fibrinolysis early Eur J Trauma Emerg Surg 2015 41 1 49 56
89. Moore H B Moore E E Chapman M P, et al. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients J Thromb Haemost 2015 13 10 1878 1887
90. Lang T von Depka M Possibilities and limitations of thrombelastometry/-graphy [in German] Hamostaseologie 2006 26 3 01 S20 S29
91. Maegele M Lefering R Yucel N, et al; AG Polytrauma of the German Trauma Society (DGU). Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients Injury 2007 38 3 298 304
92. Shakur H Roberts I Bautista R, et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet 2010 376 (9734): 23 32
93. Cole E Davenport R Willett K Brohi K Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study Ann Surg 2015 261 2 390 394
94. Morrison J J Dubose J J Rasmussen T E Midwinter M J Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study Arch Surg 2012 147 2 113 119
95. Moore H B Moore E E Morton A P, et al. Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation J Trauma Acute Care Surg 2015 79 6 897 903, discussion 903-904
96. Vulliamy P Gillespie S Gall L Brohi K Davenport R A Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage J Trauma Acute Care Surg 2013 3 1 10.1186/2110-5820-3-1
97. McCormack P L Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis Drugs 2012 72 5 585 617
98. Dubber A H McNicol G P Douglas A S Melander B Some properties of the antifibrinolytically active isomer of amino-methylcyclohexane carboxylic acid Lancet 1964 2 (7373): 1317 1319
99. Verstraete M Haemostatic Drugs: A Critical Appraisal, 1st ed The Hague Martinus Nijhoff 1977 132
100. Okamoto S Sato S Takada Y Okamoto U An active stereo-isomer (trans-form) of amcha and its antifibrinolytic (antiplasminic) action in vitro and in vivo Keio J Med 1964 13 177 185
101. Henry D Carless P Moxey A J, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 2011 3 CD001886
102. Ker K Edwards P Perel P Shakur H Roberts I Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis BMJ 2012 344 e3054
103. Dewan Y Komolafe E O Mejía-Mantilla J H Perel P Roberts I Shakur H; CRASH-3 Collaborators. CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial Trials 2012 13 87
104. Roberts I Coats T Edwards P, et al. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial Trials 2014 15 450
105. Shakur H Elbourne D Gülmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial Trials 2010 11 40
106. Roberts I Perel P Prieto-Merino D, et al; CRASH-2 Collaborators. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial BMJ 2012 345 e5839
107. Perel P Prieto-Merino D Shakur H Roberts I Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial Health Technol Assess 2013 17 24 1 45, v-vi
108. Ker K Kiriya J Perel P Edwards P Shakur H Roberts I Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial BMC Emerg Med 2012 12 3
109. Guerriero C Cairns J Perel P Shakur H Roberts I; CRASH 2 trial collaborators. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial PLoS One 2011 6 5 e18987
110. Roberts I Shakur H Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients Health Technol Assess 2013 17 10 1 79
111. Morrison J J Ross J D Dubose J J Jansen J O Midwinter M J Rasmussen T E Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study JAMA Surg 2013 148 3 218 225
112. Ker K Roberts I Shakur H Coats T J Antifibrinolytic drugs for acute traumatic injury Cochrane Database Syst Rev 2015 5 5 CD004896
113. Klein A A Arnold P Bingham R M, et al. AAGBI guidelines: the use of blood components and their alternatives 2016 Anaesthesia 2016 71 7 829 842
114. Rossaint R Bouillon B Cerny V, et al; STOP Bleeding Campaign. The STOP the Bleeding Campaign Crit Care 2013 17 2 136
115. Roberts I Shakur H Afolabi A, et al; CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Lancet 2011 377 (9771): 1096 1101, 1101.e1-1101.e2
116. Jimenez J J Iribarren J L Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial Crit Care 2007 11 6 R117
117. Godier A Roberts I Hunt B J Tranexamic acid: less bleeding and less thrombosis? Crit Care 2012 16 3 135
118. Hijazi N Abu Fanne R Abramovitch R, et al. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice Blood 2015 125 16 2558 2567
119. Medcalf R L The traumatic side of fibrinolysis Blood 2015 125 16 2457 2458
120. Faught C Wells P Fergusson D Laupacis A Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature Transfus Med Rev 1998 12 3 206 225
121. Zufferey P Merquiol F Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006 105 5 1034 1046
122. Fergusson D A Hébert P C Mazer C D, et al; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 2008 358 22 2319 2331
123. European Medicines Agency Press release February 17, 2012. Available at: www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/02/news_detail_001447.jsp&mid=WC0b01ac058004d5c1. Accessed September 10, 2016
124. Geerts W H Code K I Jay R M Chen E Szalai J P A prospective study of venous thromboembolism after major trauma N Engl J Med 1994 331 24 1601 1606
125. Selby R Geerts W Ofosu F A, et al. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism Thromb Res 2009 124 3 281 287
126. Poeran J Rasul R Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety BMJ 2014 349 g4829